● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

BROOKS

BSE
Brooks Laboratories Limited
Healthcare· Pharmaceuticals & Biotechnology· INE650L01011· Scrip: 533543
ENहिन्दीગુજરાતીमराठी
67.24
1.01 (+0.00%)
2026-06-10
BSE
67.24
1.01
+0.00%
437310313216206-1808-1110-0712-0201-2803-2505-2706-10
231 trading days · 1Y period
TODAY (BSE)
Open70.95
High70.95
Low66.00
Prev Close68.25
Volume4,478
Value₹0.0Cr
L: 66.00H: 70.95
Info
Face Value₹10
Listed2011-09-05
ISININE650L01011
SeriesT
BSE Scrip533543

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-1.33%
PAT+46.20%
EPS+45.70%
Profitability
TTM Revenue
₹77 Cr
TTM EBITDA
₹5 Cr
TTM PAT
₹-16 Cr
TTM EPS
₹-6.18
Rev/Share
₹26.1

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr6 Cr12 Cr18 Cr24 Cr22-1223-0323-0923-1224-0324-0624-0924-12-2.0-1.7-0.6-1.5-3.8-0.1-1.5-0.8
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-3121 Cr20 Cr2 Cr1 Cr-2 Cr-0.82
2024-09-3021 Cr20 Cr2 Cr1 Cr-4 Cr-1.51
2024-06-3018 Cr18 Cr0 Cr-0 Cr-0 Cr-0.08
2024-03-3118 Cr18 Cr1 Cr0 Cr-10 Cr-3.77
2023-12-3122 Cr21 Cr1 Cr1 Cr-4 Cr-1.51
2023-09-3024 Cr23 Cr2 Cr1 Cr-2 Cr-0.64
2023-03-3113 Cr13 Cr-0 Cr-1 Cr-4 Cr-1.74
2022-12-3115 Cr27 Cr-10 Cr-11 Cr-9 Cr-2.03

Shareholding Pattern

CURRENT2026-03-31
52.6%PROMOTER
Promoter52.6%
FII0.2%
DII10.4%
Public47.4%
PROMOTER HOLDING TREND
63.6%24-0959.1%24-1252.6%25-0152.6%25-0352.6%25-0952.6%25-1252.6%26-03

Corporate Actions

Ex-DateTypePurpose
2024-09-12OtherAnnual General Meeting
2023-09-14OtherAnnual General Meeting
2023-07-28RightsRights 1:16 @ Premium Rs 65/-
2022-09-22OtherAnnual General Meeting
2021-09-21Other Annual General Meeting
2020-09-18Other Annual General Meeting
2020-02-11Rights Rights 9:20 @ Premium Rs 10/-
2019-09-17Other Annual General Meeting
2018-08-02Other Annual General Meeting
2017-09-20Other Annual General Meeting
2016-09-19Other Annual General Meeting
2015-09-21Other Annual General Meeting
2014-07-31OtherAnnual General Meeting
2013-08-29OtherAnnual General Meeting
2012-09-14OtherAnnual General Meeting

Price History

DateOpenHighLowCloseVolume
2026-06-1071.0071.0066.5567.7429,803
2026-06-0369.3869.4063.7564.4033,580
2026-05-2762.0062.1958.0062.191.18L
2026-05-2659.2359.2359.2359.2355,049
2026-05-2554.8956.4154.5456.4142,943
2026-05-2251.2553.7351.2553.7353,843
2026-05-2150.6451.5049.0051.1844,589
2026-05-2049.3950.0447.1149.5159,389
2026-05-1946.9548.4246.5048.4250,829
2026-05-1847.5047.5044.5646.1249,515
2026-05-1548.8348.8346.3046.6172,190
2026-05-1446.6648.7646.6648.0021,148
2026-05-1350.8550.8547.4047.681.07L
2026-05-1248.6049.8347.4449.811.28L
2026-05-1149.4849.4847.4447.461.19L
2026-05-0853.3853.7549.9349.932.19L
2026-05-0755.2957.3552.5352.553.00L
2026-05-0654.7056.9753.0055.292.44L
2026-05-0553.5454.8853.0054.2658,938
2026-05-0456.1558.7754.0054.541.26L
2026-04-3058.8658.8655.9255.9848,992
2026-04-2961.7861.7858.7058.8691,542
2026-04-2864.4665.6461.4061.781.09L
2026-04-2769.9369.9364.1764.4688,951
2026-04-2467.1567.5765.0067.5440,572
2026-04-2361.3064.3660.5064.3629,463
2026-04-2263.9963.9961.0061.3037,303
2026-04-2166.1066.7563.1564.0423,295
2026-04-2068.1068.9064.8565.6632,647
2026-04-1770.0070.0067.0267.5840,554

Frequently Asked Questions

About

Brooks Laboratories Limited is an Indian pharmaceutical company that operates primarily on a contract basis, offering development and manufacturing services for pharmaceutical products, including contract manufacturing of various dosage forms and contract development services. Its key offerings include the production of liquid injection ampoules, vials, and dry powder formulations, catering to both domestic and international clients. Notably, the company has been in operation since its inception in 1967, establishing itself as a long-standing player in the pharmaceutical sector.

BOARD OF DIRECTORS
Atul Ranchal
Executive Director
DEPARTED
Jitendra Pratap Singh
Whole-time Director
Kaushalya Singh
Whole-time Director
DEPARTED
Manpreet Singh Naroo
Whole-time Director
DEPARTED
Rajesh Mahajan
Managing Director
DEPARTED
Rajnish Kumar Bedi
Independent Director
DEPARTED
Sonia Gupta
Independent Director
DEPARTED
Bhushan Singh Rana
Additional Director
Durga Shankar Maity
Additional Director